Key result
Prescription opioid medication use was not significantly associated with coronary artery disease (Prevalence Odds Ratio 1.39; 95% CI 0.71-2.75; p=0.34 for the first opioid group).
Why the study?
Previous studies have reported conflicting results regarding the relationship between opioid therapy and the development of cardiovascular diseases.
Does prescription opioid medication use increase the risk of coronary artery disease in adults?
Cross-Sectional (n=1,829)
Yes
Does prescription opioid medication use increase the risk of coronary artery disease in adults?
Odds Ratio: 1.39 (95% CI 0.71–2.75)
p-value: p=0.34
This study found no significant association between prescription opioid use and coronary artery disease in a cross-sectional analysis of US ambulatory care data.
No association in cross-sectional data; leaves open any causal opioid-CAD relationship requiring longitudinal study.
Approximately 2150 adults die every day in the U.S. from Cardiovascular Diseases (CVD) and another 115 deaths are attributed to opioid-related causes. Studies have found conflicting results on the relationship between opioid therapy and the development of cardiovascular diseases. This study examined whether an association exists between the use of prescription opioid medicines and cardiovascular diseases, using secondary data from the National Hospital Ambulatory Medical Care Survey (NAMCS) 2015 survey. Of the 1829 patients, 1147 (63%) were male, 1762 (98%) above 45 years of age, and 54% were overweight. The rate of cardiovascular diseases was higher among women [(p < 0.001), 95% CI: 0.40–0.51]. The covariates were age, race/ethnicity, sex, diabetes mellitus, hyperlipidemia, and hypertension; and were adjusted. Diabetes mellitus, hyperlipidemia, and hypertension were significant predictors of CVD [(p < 0.001, 95% CI: 0.57–0.78); (p < 0.001, 95% CI: 0.34–0.44); (p < 0.001, 95% CI: 0.49–0.59)]. There was no significant association between prescription opioid medication use and coronary artery disease [first opioid group p = 0.34, Prevalence Odds Ratio (POR): 1.39, 95% CI: 0.71–2.75; second opioid group: p = 0.59, POR: 1.20, 95% CI: 0.61–2.37, and third opioid group: p = 0.62, POR: 0.85, 95% CI: 0.45–1.6]. The results of this study further accentuate the conflicting results in literature. Further research is recommended, with a focus on those geographical areas where high prevalence of cardiovascular diseases exists.
No takes yet. Share an insight, caveat, or question.
Ogungbe et al. (2019) conducted a cross-sectional in Cardiovascular diseases (n=1,829). Prescription opioid medicines vs. No prescription opioid use was evaluated on Coronary artery disease (POR 1.39, 95% CI 0.71-2.75, p=0.34). Prescription opioid medication use was not significantly associated with coronary artery disease (Prevalence Odds Ratio 1.39; 95% CI 0.71-2.75; p=0.34 for the first opioid group).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: